SELB
Income statement / Annual
Last year (2023), Selecta Biosciences, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Selecta Biosciences, Inc.'s net income was -$219.71 M.
See Selecta Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00
|
$110.78 M
|
$85.08 M
|
$16.60 M
|
$6.68 M
|
$903,000.00
|
$207,000.00
|
$8.08 M
|
$6.01 M
|
$3.04 M
|
| Cost of Revenue |
$0.00 |
$72.38 M |
$68.74 M |
$54.51 M |
$42.74 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$38.40 M |
$16.34 M |
-$37.91 M |
-$36.07 M |
$903,000.00 |
$207,000.00 |
$8.08 M |
$6.01 M |
$3.04 M |
| Gross Profit Ratio |
0 |
0.35 |
0.19 |
-2.28 |
-5.4 |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$71.84 M
|
$72.38 M
|
$68.74 M
|
$54.51 M
|
$42.74 M
|
$47.69 M
|
$45.17 M
|
$29.70 M
|
$22.98 M
|
$10.49 M
|
| General & Administrative
Expenses |
$40.58 M
|
$23.86 M
|
$20.94 M
|
$18.91 M
|
$16.39 M
|
$18.24 M
|
$18.83 M
|
$13.05 M
|
$8.34 M
|
$7.95 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$40.58 M
|
$23.86 M
|
$20.94 M
|
$18.91 M
|
$16.39 M
|
$18.24 M
|
$18.83 M
|
$13.05 M
|
$8.34 M
|
$7.95 M
|
| Other Expenses |
$0.00 |
$330,000.00 |
$15,000.00 |
$89,000.00 |
-$1.31 M |
$10,000.00 |
-$152,000.00 |
$4,000.00 |
-$26,000.00 |
-$44,000.00 |
| Operating Expenses |
$112.42 M |
$96.24 M |
$89.67 M |
$73.42 M |
$59.13 M |
$65.93 M |
$63.99 M |
$42.75 M |
$31.32 M |
$18.44 M |
| Cost And Expenses |
$112.42 M |
$96.24 M |
$89.67 M |
$73.42 M |
$59.13 M |
$65.93 M |
$63.99 M |
$42.75 M |
$31.32 M |
$18.44 M |
| Interest Income |
$0.00 |
$958,000.00 |
$2.80 M |
$1.30 M |
$834,000.00 |
$1.05 M |
$617,000.00 |
$234,000.00 |
$171,000.00 |
$111,000.00 |
| Interest Expense |
-$2.83 M |
$3.03 M |
$2.84 M |
$1.56 M |
$1.52 M |
$1.49 M |
$1.21 M |
$1.25 M |
$948,000.00 |
$552,000.00 |
| Depreciation &
Amortization |
$764,000.00
|
$1.62 M
|
$15,000.00
|
$89,000.00
|
-$1.31 M
|
$975,000.00
|
$750,000.00
|
$802,000.00
|
$1.04 M
|
$864,000.00
|
| EBITDA |
-$86.42 M
|
$16.16 M
|
-$4.58 M
|
-$56.73 M
|
-$53.76 M
|
-$65.01 M
|
-$63.94 M
|
-$34.67 M
|
-$24.29 M
|
-$14.58 M
|
| EBITDA Ratio |
0 |
0.15 |
-0.05 |
-3.42 |
-8.05 |
-72 |
-308.87 |
-4.29 |
-4.04 |
-4.8 |
| Operating Income Ratio
|
0
|
0.13
|
-0.05
|
-3.42
|
-7.86
|
-72.01
|
-308.14
|
-4.29
|
-4.21
|
-5.07
|
| Total Other
Income/Expenses Net |
-$152.29 M
|
$20.23 M
|
-$5.12 M
|
-$12.06 M
|
-$2.90 M
|
-$314,000.00
|
-$1.54 M
|
-$1.54 M
|
$130,000.00
|
$2.52 M
|
| Income Before Tax |
-$238.71 M |
$34.77 M |
-$9.72 M |
-$68.88 M |
-$55.35 M |
-$65.34 M |
-$65.32 M |
-$36.21 M |
-$25.17 M |
-$12.88 M |
| Income Before Tax Ratio
|
0
|
0.31
|
-0.11
|
-4.15
|
-8.29
|
-72.35
|
-315.56
|
-4.48
|
-4.19
|
-4.24
|
| Income Tax Expense |
$19.00 M |
-$609,000.00 |
$15.97 M |
$911,000.00 |
-$1.81 M |
$1.18 M |
$304,000.00 |
$455,000.00 |
$922,000.00 |
$508,000.00 |
| Net Income |
-$219.71 M |
$35.38 M |
-$25.69 M |
-$69.79 M |
-$53.54 M |
-$65.34 M |
-$65.32 M |
-$36.21 M |
-$25.17 M |
-$12.88 M |
| Net Income Ratio |
0 |
0.32 |
-0.3 |
-4.2 |
-8.02 |
-72.35 |
-315.56 |
-4.48 |
-4.19 |
-4.24 |
| EPS |
-0.0014 |
0.24 |
-0.22 |
-0.69 |
-1.18 |
-2.92 |
-3.2 |
-3.45 |
-1.96 |
-1 |
| EPS Diluted |
-0.0014 |
0.1 |
-0.22 |
-0.69 |
-1.18 |
-2.92 |
-3.2 |
-3.45 |
-1.96 |
-1 |
| Weighted Average Shares
Out |
$155.11 B
|
$144.76 M
|
$114.33 M
|
$101.20 M
|
$45.55 M
|
$22.39 M
|
$20.43 M
|
$10.49 M
|
$12.87 M
|
$12.87 M
|
| Weighted Average Shares
Out Diluted |
$155.11 B
|
$145.87 M
|
$114.33 M
|
$101.20 M
|
$45.55 M
|
$22.39 M
|
$20.43 M
|
$10.49 M
|
$12.87 M
|
$12.87 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
